Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma

miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway

(2015) Zhiyong Yan et al.   TUMOR BIOLOGY

Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas

(2015) Yanwei Liu et al.   Oncotarget

A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway

(2015) Jin Meng et al.   Oncotarget

Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion

(2014) V. R. Praveen Kumar et al.   JOURNAL OF NEURO-ONCOLOGY

Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma

(2014) Ye Song et al.   Molecular Cancer

Long non-coding RNAs in the regulation of the immune response

(2014) James A. Heward et al.   TRENDS IN IMMUNOLOGY

Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter

(2013) Ryan C Thompson et al.   BMC MOLECULAR BIOLOGY

AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression

(2013) Z. Shi et al.   CANCER RESEARCH

The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance

(2013) Florian A. Siebzehnrubl et al.   EMBO Molecular Medicine

HOTAIR, a cell cycle–associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma

(2013) Jun-Xia Zhang et al.   NEURO-ONCOLOGY

MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1

(2013) Jianwen Zhou et al.   PLoS One

Posttranscriptional Gene Regulation by Long Noncoding RNA

(2012) Je-Hyun Yoon et al.   JOURNAL OF MOLECULAR BIOLOGY

A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma

(2012) Wei-Yi Cheng et al.   PLoS One

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

(2011) K. Vargova et al.   BLOOD

Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo

(2011) Dimitris Anastassiou et al.   BMC CANCER

Silencing of microRNA families by seed-targeting tiny LNAs

(2011) Susanna Obad et al.   NATURE GENETICS

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

(2011) Suhwan Chang et al.   NATURE MEDICINE

The Emergence of lncRNAs in Cancer Biology

(2011) J. R. Prensner et al.   Cancer Discovery

HOXA9 regulates miR-155 in hematopoietic cells

(2010) Y.-L. Hu et al.   NUCLEIC ACIDS RESEARCH

Cutting Edge: The Foxp3 Target miR-155 Contributes to the Development of Regulatory T Cells

(2009) S. Kohlhaas et al.   JOURNAL OF IMMUNOLOGY

Small-Molecule Inhibitors of MicroRNA miR-21 Function

(2008) Kiranmai Gumireddy et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype

(2008) D. Sarrio et al.   CANCER RESEARCH

MicroRNA-155 Is Regulated by the Transforming Growth Factor  /Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

(2008) W. Kong et al.   MOLECULAR AND CELLULAR BIOLOGY

The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data

(2008) Marc Parisien et al.   NATURE

Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration

(2008) Y Wu et al.   ONCOGENE

Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs

(2007) Ming Yang et al.   PHARMACOLOGY & THERAPEUTICS